GSK reports positive pivotal phase III data for next-generation low carbon version of Ventolin metered dose inhaler: London, UK Thursday, October 23, 2025, 11:00 Hrs [IST] GSK plc ...

GSK (GSK) announced positive phase III data from its clinical program to develop a next-generation version of its metered dose inhaler, Ventolin.

Prescribing inhalers offers physicians a chance to impact climate change — but switching to greener options comes with ...

NOW THAT THE EV TAX CREDIT IS GONE, THE MILLIONS OF AMERICANS WHO STRUGGLE WITH CHRONIC LUNG DISEASE, INCLUDING ASTHMA, MAY BE ADDING TO A GLOBAL ISSUE, ACCORDING TO NEW RESEARCH. MEDICATION INHALER ...

The study, published in the Journal of the American Medical Association (JAMA) on Monday, found that inhalers used by US ...